fatnews.com Home page  >  Article | Previous article | Next article

SEARCH

QUICKLINKS AND VIEW OPITONS

  • Categories of Articles
  • Summary View
  • Headline View
  • Archive of Quotes
  • Contact Us
  • Follow @fatnews

    Type 2 diabetics given once-a-week Byetta injections lose 8.4 lbs in four months


    Posted by .(JavaScript must be enabled to view this email address)
    Tuesday, March 25, 2008 7:29 am Email this article
    Type 2 diabetics who were injected once-a-week with with 2 mg of long-acting release Byetta lost an average of 8.4 pounds after 3.75 months (15 weeks) according to a recent study from researchers at Amylin Pharmaceuticals, the makers of the drug. Patients given a dose of 0.8 mg once a week or a placebo did not lose weight. The long-acting release formula is under development by Amylin Pharmaceuticals, Inc. in San Diego, California, USA. Blood Sugar Levels

    A1C of 7% or less achieved by 36% of those given 0.8 mg per week, and 86% of those given 2 mg per week

    A1C of 7% or less was achieved by 36% of patients given 0.8 mg per week, and 86% of subjects given 2 mg per week compared with 0% of subjects receiving placebo.   

    A1C is short for glycosylated hemoglobin A1c, a marker of blood sugar levels over time.

     

    Side Effects

    Side effects : Mild nausea was the most common side effect—27% vs 19% vs 15%—no vomiting

    Mild nausea was the most common side effect occurring in 27 percent of those receiving 2 mg per week versus 19 percent in those receiving 0.8 mg per week, and 15 percent in those receiving an injection of placebo.

    “All episodes of nausea were mild, with no reports of vomiting,” the paper notes.

    Side effects : Gastroenteritis—13% vs 19% vs 0%

    Gastroenteritis—an irritation of the gut—occurred in 13 percent of those receiving 2 mg per week versus 19 percent in those receiving 0.8 mg per week, and 0 percent in those receiving an injection of placebo.

    Side effects : Hypoglycemia—0% vs 25% vs 0%

    Hypoglycemia—abnormally low blood sugar—occurred in 0 percent of those receiving 2 mg per week versus 25 percent in those receiving 0.8 mg per week, and 0 percent in those receiving an injection of placebo. ( This does not make sense that the lower dose would cause more hypoglycemia, but that is what the paper says. I would not be surprised if the numbers are backwards. )

    Side effects : No withdrawals due to side effects

    “There were no withdrawals because of adverse events during exenatide LAR treatment,” the authors also noted.

     

    Subjects

    Subjects : 45 people

    The study involved 45 people with type 2 diabetes.

    They had had diabetes for an average of 5.4 years.

     

    Metformin

    60% were taking metformin

    Sixty percent of patients were taking metformin.

    The dose of metformin ranged from 500 to 2550 mg per day.

    REFERENCE

    Kim D, Macconell L, Zhuang D, Kothare P, Trautmann M, Fineman M, Taylor K. Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes. Diabetes Care. 2007 Jun, 30(6):1487-93.

    AUTHOR’S CONTACT INFORMATION

    D. Kim
    Amylin Pharmaceuticals, Inc.
    San Diego, California 92121, USA
    .(JavaScript must be enabled to view this email address)

    Articles on the same subject can be found here:


    COMMENTS

    Please feel free to share your comments about this article.


    Name:

    Email:

    Comments:

    Please enter the word you see in the image below:


    Remember my personal information

    Notify me of follow-up comments?



    © Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.